MHRA Fees – Fees Payable to MHRA for 2022 to 2023 MHRA Fees – Fees Payable to MHRA for 2022 to 2023 On 5 September 2022 MHRA published ‘Statutory Guidance –... MHRA Fees – Fees Payable to MHRA for 2022 to 2023
Digital Application Dataset Integration (DADI) User Acceptance Testing (UAT) for CAPs Postponed Digital Application Dataset Integration (DADI) User Acceptance Testing (UAT) for CAPs Postponed Due to additional work needed on the platform,... Digital Application Dataset Integration (DADI) User Acceptance Testing (UAT) for CAPs Postponed
MHRA Consultation on Proposals to Increase Statutory Fees Published MHRA Consultation on Proposals to Increase Statutory Fees Published MHRA is seeking views on proposals for changes to statutory fees... MHRA Consultation on Proposals to Increase Statutory Fees Published
Draft EU Public Statement on Foeniculi amari fructus aetheroleum – Consultation Draft EU Public Statement on Foeniculi amari fructus aetheroleum – Consultation Further to its adoption by the EMA Committee on... Draft EU Public Statement on Foeniculi amari fructus aetheroleum – Consultation
Draft EU Monograph on Juniperi pseudo-fructus – Consultation Draft EU Monograph on Juniperi pseudo-fructus – Consultation Further to its adoption by the EMA Committee on Herbal Medicinal Products... Draft EU Monograph on Juniperi pseudo-fructus – Consultation
Equity in Medical Devices: Independent Review Call for Evidence – DHSC Webinar Equity in Medical Devices: Independent Review Call for Evidence – DHSC Webinar DHSC is hosting a webinar on Wednesday 7... Equity in Medical Devices: Independent Review Call for Evidence – DHSC Webinar
Draft EU Monograph on Foeniculi dulcis fructus – Consultation Draft EU Monograph on Foeniculi dulcis fructus – Consultation Further to its adoption by the EMA Committee on Herbal Medicinal... Draft EU Monograph on Foeniculi dulcis fructus – Consultation
Draft EU Monograph on Foeniculi amari fructus – Consultation Draft EU Monograph on Foeniculi amari fructus – Consultation Further to its adoption by the EMA Committee on Herbal Medicinal... Draft EU Monograph on Foeniculi amari fructus – Consultation
EMA Webinar Series – September 2022 EMA Webinar Series – September 2022 The European Medicines Agency (EMA) will be hosting a series of webinars in September... EMA Webinar Series – September 2022
EMA HMPC – Final Public Statement on Salvia miltiorrhiza Bunge, radix et rhizome EMA HMPC – Final Public Statement on Salvia miltiorrhiza Bunge, radix et rhizome The European Medicines Agency (EMA) Committee on... EMA HMPC – Final Public Statement on Salvia miltiorrhiza Bunge, radix et rhizome
Prolongation of Signal Detection in EudraVigilance Pilot EMA Prolongs Signal Detection in EudraVigilance Pilot The European Medicines Agency (EMA) has announced that the pilot of monitoring of... Prolongation of Signal Detection in EudraVigilance Pilot
EMA Reminder – Companies to Register their Industry Single Point of Contact (i-SPOC) on Supply and Availability EMA Reminder – Companies to Register their Industry Single Point of Contact (i-SPOC) on Supply and Availability EMA has issued... EMA Reminder – Companies to Register their Industry Single Point of Contact (i-SPOC) on Supply and Availability
